Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Life Sciences : CMLS|December 26, 2024
Amiloride sensitizes prostate cancer cells to the reversible tyrosine kinase inhibitor lapatinib by modulating Erbb3 subcellular localizationMaitreyee K Jathal, Maria Mudryj, Marc A Dall'Era, et al.
Journal of Virology|March 22, 2002
Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycleThomas Ndolo, Navdeep K Dhillon, Hau Nguyen, et al.
Biomedicines|October 23, 2021
Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and HumansMaria Malvina Tsamouri, Thomas M Steele, Maria Mudryj, et al.
The Journal of Biological Chemistry|December 1, 2009
ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell linesHonglin Chen, Stephen J Libertini, Yu Wang, et al.
Urology|October 2, 2007
Novel p53/p130 axis in bladder tumorsMaria Mudryj, Elizabeth Reay, Laurel Beckett, et al.
The Prostate|August 23, 2005
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosisStephen J Libertini, Clifford G Tepper, Moraima Guadalupe, et al.
International Journal of Molecular Sciences|July 29, 2023
Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization StrategiesChristopher A Lucchesi, Demitria M Vasilatis, Saisamkalpa Mantrala, et al.
Cancer Research|October 3, 2007
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independenceStephen J Libertini, Clifford G Tepper, Veronica Rodriguez, et al.
The Prostate|August 13, 2011
The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cellsStephen J Libertini, Honglin Chen, Bushra al-Bataina, et al.
The Journal of Urology|August 27, 2014
The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidenceBenjamin A Mooso, Ruth L Vinall, Maria Mudryj, et al.
Pageof 4